Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, cash reserves at Neurosense Therapeutics Ltd fell by 903.00k. Cash Flow from Financing totalled 3.90m or -- of revenues. In addition the company used 8.45m for operations while cash from investing totalled 3.65m.
Cash flow per share | -- |
---|---|
Price/Cash flow per share | -- |
Book value per share | -0.0943 |
---|---|
Tangible book value per share | -0.0943 |
More ▼
Balance sheet in USDView more
Current ratio | 0.4615 |
---|---|
Quick ratio | -- |
Total debt/total equity | -- |
---|---|
Total debt/total capital | -- |
More ▼